Although the premise that biological aging can be halted or reversed by foreseeable technology remains controversial,[24] research into developing possible therapeutic interventions is underway.[25] Among the principal drivers of international collaboration in such research is the SENS Research Foundation, a non-profit organization that advocates a number of what it claims are plausible research pathways that might lead to engineered negligible senescence in humans.[26]